<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5009812 Figure_2-A</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Huh7 cells were co-transfected with shRNAs fulfilling all requirements for incorporation into the expression strategies from Figure 1C and the HBV expression plasmid pCH-HBV1.3, and HBeAg and HBsAg were quantified in the supernatant 48 h later. An empty AAV vector plasmid was used as control. Another negative control were mock-transfected cells.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_2-B</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. The same experiment was repeated with plasmid pCH-9-3091, which contains a 1.1-fold over-length HBV genome. HBV DNA in supernatant was measured at day four via PCR, using primers that preferentially amplify HBV rcDNA rather than the 1.1-fold over-length HBV sequence contained in the plasmid.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_2-C</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. RT-qPCR results from cell lysates (same experiment as in panel A) with primers specific for the 3.5 kb HBV transcripts (consisting of pregenomic [pg] RNA and the precore transcript; left), or with primers that detect all HBV transcripts (right).</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_2-D</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Southern blot analysis of lysates obtained 72 h post-transfection of HepG2 cells treated with the same plasmids as in panel A.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_3-B</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Measurement of resulting luciferase activities in cell lysates 48 h post-transfection. Note the potent inhibition of shHBV7 sense strand activity with the specific TuDHBV7, without interference with the antisense strand (compare left two orange or blue bars, respectively). bs, binding site.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_3-C</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. In vivo evaluation of different shRNA and TuD combinations after packaging into double-stranded AAV8 vectors and intravenous (i.v.) injection of 1x1011 particles into HBV-transgenic mice (HBV1.3.32). Anti-HBV activity was determined by measuring HBsAg and HBeAg levels in the serum of treated animals at the indicated time points post-AAV injection.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_4-A</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Huh7 cells were co-transfected with the HBV expression plasmid pCH-HBV1.3 and the four principal constructs examined in this study, or with an empty AAV expression plasmid that served as negative control. Another negative control were mock-transfected cells. HBeAg and HBsAg were quantified in the supernatant48 h later.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_4-B</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Measurement of HBV DNA in cell culture supernatants four days after co-transfection of Huh7 cells with the plasmid encoding the 1.1-fold over-length HBV sequence (pCH-9-3091) and the same RNAi expression plasmids as in panel A. PCR was performed using primers that discriminate between HBV rcDNA and the 1.1-fold over-length HBV sequence contained in the plasmid.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_4-C</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. RT-qPCR results using primers specific for the 3.5 kb HBV transcript (including pregenomic RNA and the precore transcript; left), or primers that detect all HBV transcripts (right).</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_4-D</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. Southern blot analysis of lysates obtained 72 h post-transfection of HepG2 cells with the same plasmids as described in panel A.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_5-B</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>B to D. Determination of anti-HBV efficacy and safety by measuring HBsAg in the serum of treated mice (B).</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_5-C</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>B to D. Determination of anti-HBV efficacy and safety of treated mice by measuring their body weight (C).</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_5-D</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>B to D. Determination of anti-HBV efficacy and safety of treated mice by measuring serumALT levels (D).</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_5-E</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. Hematoxylin/Eosin (HE) stains of livers harvested on day 84. Scale bar at bottom right represents 100 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_6-A</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. HBV-transgenic mice (5 in mock group, 6 in all others) were injected intravenously with 1x1011 particles of the shown AAV8 vectors, and HBsAg was measured from serum at various time points post-injection. Fifteen days post-treatment, mRNA expression in livers was analysed using microarrays. Significance was calculated using student t-test.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_6-C</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Transcripts of genes significantly up- or down-regulated by shHBV7 were analysed for the presence of shHBV7 sense or antisense 2-7 nt seed matches and compared to the background frequency within all genes on the microarray. Significance was calculated using Chi-square test with Yates' correction.</text>
    </passage>
  </document>
  <document>
    <id>5009812 Figure_6-D</id>
    <infon key="sourcedata_document">2150</infon>
    <infon key="doi">10.15252/emmm.201506172</infon>
    <infon key="pmc_id">5009812</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>D. All genes on the microarray were grouped according to the presence of 3'UTR shHBV7 sense or antisense seed matches. Shown is their relative expression compared to the empty vector. Significance was calculated using Mann-Whitney test.</text>
    </passage>
  </document>
</collection>
